產(chǎn)品詳情
| 中文名稱:比馬前列素 | 英文名稱:N-ETHYL-9ALPHA,11ALPHA,15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z, 13E-DIEN-1-AMIDE; LUMIGAN; BIMATOPROST(TM); 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA ETHYL AMIDE; BIMATOPROST(LUMIGAN); 17-phenyl-tri-norprostaglandin f2α-ethyl amide; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide; (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide; (5E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide |
| CAS:155206-00-1 | 有效期: 一年 |
2016-05-30
比馬前列素
N-ETHYL-9ALPHA,11ALPHA,15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z, 13E-DIEN-1-AMIDE; LUMIGAN; BIMATOPROST(TM); 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA ETHYL AMIDE; BIMATOPROST(LUMIGAN); 17-phenyl-tri-norprostaglandin f2α-ethyl amide; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide; (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide; (5E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
RMB
1
一年
比馬前列素
中文別名:(Z)-7-[(1R,2R,3R,5S)-3,5-二羥基-2-[(E,3S)-3-羥基-5-苯基戊-1-烯基]環(huán)戊基]-N-乙基庚-5-烯酰胺
英文別名:N-ETHYL-9ALPHA,11ALPHA,15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z, 13E-DIEN-1-AMIDE; LUMIGAN; BIMATOPROST(TM); 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA ETHYL AMIDE; BIMATOPROST(LUMIGAN); 17-phenyl-tri-norprostaglandin f2α-ethyl amide; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide; (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide; (5E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
CAS:155206-00-1
EINECS:-[2]
相對(duì)密度:1.145g/cm3
比馬前列素被認(rèn)為是目前降IOP作用最強(qiáng)的局部抗青光眼藥物，對(duì)正常人、POAG和OHT患者均有效，主要用于不能耐受其他降IOP藥或使用其他降IOP藥物無(wú)效的POAG或OHT患者。
湖北鴻鑫瑞宇歡迎您！
聯(lián)系人：劉經(jīng)理/陳經(jīng)理/李經(jīng)理/胡經(jīng)理/袁經(jīng)理
電話：027-65526669；027-50467608；027-65385071；027-65381247；027-65021350；
手機(jī)：13886177946；15102793023；17771852910；15671591110；18164064948；QQ:2545103399；2251984933；3249233854；3074722151；2016269472；3030382562
旺旺/貿(mào)易通：hxry2014001；hxry200520797118；hxry1999；hxry2003；hxry2001；鴻鑫瑞宇
關(guān)鍵字： 比馬前列素
公司簡(jiǎn)介
| 成立日期 |
2014-12-09
（11年）
|
注冊(cè)資本 |
101萬(wàn)人民幣
|
| 員工人數(shù) |
|
年?duì)I業(yè)額 |
|
| 主營(yíng)行業(yè) |
醫(yī)藥中間體,原料藥 |
經(jīng)營(yíng)模式 |
貿(mào)易,工廠 |